What is the average cost of a pharmaceutical product recall?

A pharmaceutical recall stacks seven cost categories: (1) notification of wholesalers, pharmacies, hospital systems, prescribers and, where required, patients; (2) retrieval and reverse logistics; (3) destruction and certified disposal, with witness requirements for DEA controlled substances; (4) replacement supply for downstream purchasers; (5) regulatory consulting, legal and FDA response; (6) lost gross profit while product is off the market or a line is shut down; and (7) third-party litigation defense and indemnity.

Which of these dominates depends on the recall class FDA assigns under 21 CFR 7.3(m). Class I means a reasonable probability that use of the product will cause serious adverse health consequences or death. Class II means use may cause temporary or medically reversible harm, or the probability of serious harm is remote. Class III means use is not likely to cause adverse health consequences. Class I events carry the litigation exposure; Class II and III costs are mostly operational: retrieval, replacement and lost production.

Insurer claims data (all industries): Allianz Global Corporate & Specialty analyzed 367 product recall insurance claims from 28 countries between 2012 and the first half of 2017. The average significant claim, defined as EUR 5 million or more, exceeded $12 million (EUR 10.5 million). Losses were concentrated: over half the total came from just 10 incidents. This is a cross-industry figure, not a pharmaceutical one, and it counts only insured losses.

A single drug recall: in late 2011 Novartis recalled 1,645 lots of Excedrin, NoDoz, Gas-X and Bufferin made at its Lincoln, Nebraska plant. The company said it expected a $120 million fourth-quarter charge for the recalls. A Leerink Swann analyst estimated the full cost in lost sales and lost production at $560 million to $750 million, depending on how long the plant stayed shut.

What is not public: no FDA, academic or industry source we could find publishes an average recall cost for pharmaceutical manufacturers. Treat any single "average" figure without a named source with caution, including figures that appear in broker and vendor marketing.

Products liability responds to third-party bodily injury and property damage caused by the recalled product, which is item 7 above. The standard commercial general liability form excludes the cost of recalling, withdrawing or replacing your own product, and most life sciences products policies carry the same exclusion or only a small sublimit for recall expense.

That leaves items 1 through 6, the company's own recall cost, uninsured unless the manufacturer buys dedicated product recall coverage. Those first-party costs are the ones the Novartis example shows can run into the hundreds of millions.

Product recall insurance is a separate first-party policy. It can fund notification, retrieval, destruction, replacement, regulatory consulting, crisis communications and lost gross profit, the costs a products liability policy leaves with the manufacturer. Some forms also cover the recall costs a customer or sponsor charges back to a contract manufacturer.

Wording matters as much as the limit. Check whether the trigger requires a government-mandated recall or also covers a voluntary recall, whether lost gross profit is included or sublimited, and whether costs charged back by a sponsor or distributor are covered.

Size the limit against your own numbers rather than an industry average: the gross profit of your largest product or line over a realistic shutdown period, plus the retrieval and replacement cost for one full distribution cycle of that product. Distribution scope (national or regional), the FDA recall class your products would most likely fall into, and any limit required by a sponsor MSA or purchase contract set the floor.

Underwriters ask about recall preparedness: documented mock recalls, lot traceability, supply chain mapping and a crisis communications plan. A prior recall history is the biggest factor against you.